ResMed | RMD - 销售毛利

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.66B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	销售毛利	更改		日
Ansell	USD 326.2M		27.6M	2024-06
Artivion	USD 73.14M		1.25M	2025-12
AtriCure	USD 109.31M		3.97M	2026-03
Baxter International	USD 891M		314M	2026-03
Cochlear	AUD 856.8M		430M	2025-12
Cooper Companies	USD 735.4M		40.2M	2026-03
CSL	USD 4.46B		2.71B	2025-12
Dexcom	USD 750.3M		42.4M	2026-03
Edwards Lifesciences	USD 1.29B		59.4M	2026-03
Fisher Paykel Healthcare	NZD 784.4M		98.7M	2026-06
Globus Medical	USD 496.26M		39.69M	2026-03
Haemonetics	USD 202.39M		7.64M	2025-12
Idexx Laboratories	USD 722.74M		64.62M	2026-03
Inogen	USD 41.34M		1.39M	2024-09
Insulet	USD 540.8M		27.8M	2026-03
Integra LifeSciences	USD 213.21M		3.89M	2026-03
Intuitive Surgical	USD 1.83B		73.8M	2026-03
Medtronic	USD 6.01B		595M	2026-03
Philips	EUR 1.77B		522M	2026-03
Ramsay Health Care	AUD 549.95M		5.77B	2025-06
ResMed	USD 890.98M		12.26M	2026-03
Sigma Healthcare	AUD 160.13M		10.55M	2024-07
Sonic Healthcare	AUD 3.92B		3.14B	2024-12
Steris	USD 655.5M		9.6M	2025-12
Teleflex	USD 307.43M		21K	2026-03
Thermo Fisher Scientific	USD 4.49B		146M	2026-03